Composition for diagnosing or prognosising gliomas and a method for providing information for gliomas using same marker

摘要

A composition for diagnosing or predicting prognosis of glioma containing an agent that detects a mutation in a target gene, a biomarker panel and kit, a method of providing information on the diagnosis or prognosis of glioma, and an individual about glioma It relates to a biomarker panel for personalized medicine and a method of providing information for personalized treatment. SAMD11, KLHL21, FAM167B, HPCAL4, GPBP1L1, LPHN2, GPR88, ZNF599, C19ORF33, B9D2, BCAM, CABP5, SIGLEC11, ERVV-2, ZNF865, MZF1, MRTO4, LRIG30AND, and SLC30AND according to one aspect. When a gene or protein mutation in one or more selected target genes is detected, the accuracy of diagnosis for glioma diagnosis is high and the sensitivity is high, enabling effective glioma diagnosis. Therefore, the use of an agent for detecting gene mutations in the target gene can be usefully used in a composition for diagnosis or prognosis of glioma, a kit, a method of providing information, and a method of providing information for personalized treatment.